Psychological and behavioral burden of scabies: a comprehensive cross-sectional analysis of pruritus, anxiety, behavioral adaptation, and quality of life Authors: Özlem Akın, Özlem Tanrıöver Published: 2026 ABSTRACT AbstractBackgroundScabies is a readily transmissible parasitic skin disease frequently seen in primary care and characterized by intense pruritus. While its clinical features are well described, the psychological and behavioral aspects of scabies, including anxiety, maladaptive behaviors, and their effect on quality of life, remain insufficiently explored.ObjectivesThe aim of this study was to evaluate the clinical, psychological, and behavioral impact of scabies and to examine the associations between anxiety, behavioral changes, pruritus severity, and dermatology-related quality of life (DLQI).MethodsIn this cross-sectional study, adults with confirmed scabies, diagnosed according to the 2020 International Alliance for the Control of Scabies (IACS) criteria, were included. Participants completed an online questionnaire assessing pruritus severity, pre- and post-treatment pruritus duration, behavioral changes, anxiety measured by the Generalized Anxiety Disorder-7 (GAD-7), and DLQI. Non-parametric tests, Spearman correlation analyses, and multivariable linear regression with robust standard errors were used to evaluate associations between clinical and psychosocial variables.ResultsA total of 173 participants were analyzed (median age 37 years [IQR 27–46]; 48.6% female). Median pruritus severity was high (8.0 [7.0–10.0]), while median GAD-7 and DLQI scores were 4.0 [2.0–7.0] and 8.0 [1.0–18.0], respectively. Pruritus severity was significantly correlated with behavioral change (ρ = 0.27, p < 0.001) but not with anxiety or quality-of-life impairment. In contrast, DLQI showed significant correlations with anxiety (ρ = 0.379, p < 0.001) and behavioral change (ρ = 0.211, p = 0.005). Pre-infestation fear of scabies was associated with nearly two-fold higher anxiety scores (median GAD-7 7.0 vs. 3.5, p < 0.001) and greater behavioral change. Nodular scabies independently predicted greater impairment in quality of life in multivariable analysis (β = 3.25, p = 0.047).ConclusionsQuality-of-life impairment in scabies was more closely related to anxiety scores and nodular presentation than to itch intensity alone. Anxiety and behavioral responses were significantly associated with DLQI scores, suggesting that management should address more than antiparasitic treatment and include psychological and behavioral dimensions. As most patients are initially evaluated in primary care, these factors can be assessed during early consultations, alongside standard treatment.Supplementary InformationThe online version contains supplementary material available at 10.1186/s12875-026-03417-z.Keywords: Scabies, Pruritus, Anxiety, Behavioral change, Quality of life, Primary care Introduction Scabies is a readily transmissible ectoparasitic skin infestation caused by Sarcoptes scabiei var. hominis, which burrows into the skin and causes severe itching. Its global prevalence exceeds 200 million cases annually and poses a significant burden on both infected individuals and the healthcare system, regardless of a country’s socioeconomic status [1, 2]. It is considered a neglected tropical disease, mainly due to inadequate public and healthcare provider awareness. It manifests worldwide distribution and outbreaks among vulnerable groups, such as nurseries, retirement homes, schools, and healthcare institutions [3, 4]. It is among the most frequent causes of pruritic dermatoses encountered in primary care practice [5], and the primary care system is considered the frontline in managing such outbreaks [6]. Patients typically present first with intense nocturnal pruritus together with a history of family-wide symptoms, making primary care the main setting for diagnosis and treatment [2]. Early diagnosis and appropriate treatment in primary care can help to reduce transmission, prevent reinfestation, and lower community-level disease burden. The primary manifestation of scabies infection is intense itching. This itch is experienced by nearly all individuals affected by scabies and is the most burdensome symptom. After effective treatment, pruritus usually resolves gradually within 7–10 days, but complete resolution may take up to 4 weeks [2]. However, clinical resolution does not always parallel symptom resolution. Even after appropriate scabicidal therapy and mite eradication, some patients continue to experience persistent itch for weeks or even months. In rare cases, it can even progress into a delusional parasitosis related to scabies [7]. Ongoing symptoms after successful treatment may lead to unnecessary retreatment, further impairment of the skin barrier, and repeated healthcare visits, thereby increasing both individual and healthcare system burden [8, 9]. Pruritus associated with scabies may be accompanied by a substantial psychological burden. Chronic pruritus has been linked to anxiety, sleep disturbance, and reduced quality of life in affected patients [10, 11]. Although the psychosocial impact of scabies has been described in previous studies, behavioral adaptations following infestation and treatment have not been systematically characterized. Scabies may lead some patients to adopt behaviors such as excessive cleaning, frequent washing, social withdrawal, or repeated checking of their skin. These responses can increase distress and may result in repeated visits to healthcare services. The psychological and behavioral impact of scabies has not been examined in detail, especially in primary care, where most patients are first assessed and followed. Therefore, our aim was to evaluate the behavioral and psychological burden of scabies and to identify the factors, including anxiety symptoms, behavioral responses, and clinical characteristics, that independently contribute to quality-of-life impairment. Methods Study design and population This was a cross-sectional survey conducted among individuals previously diagnosed and treated for scabies. Scabies diagnosis was established according to the 2020 International Alliance for the Control of Scabies (IACS) Consensus Criteria [12]. The study population was restricted to patients with confirmed scabies, defined by the presence of mites, eggs, or fecal pellets identified by dermoscopic examination. Patients classified as clinical or suspected scabies were not included. All patients were managed in accordance with the current national scabies treatment recommendations in Türkiye [2]. Treatment approaches included topical permethrin, sulfur-containing topical preparations, and/or oral ivermectin according to clinical indication and current national treatment recommendations. Standard recommendations included treatment of close contacts, washing or ironing recently used clothes and bedding, and routine environmental cleaning measures. Written informed consent was obtained from all participants prior to their participation in the study. Participants completed a structured online questionnaire. The interval between treatment completion and survey completion was calculated in months for each participant. All participants were recruited from Istanbul, a large cosmopolitan metropolitan city in Türkiye. Participation was voluntary and anonymous. No personally identifiable information was retained. This study was conducted and reported in accordance with the STROBE guidelines for cross-sectional studies. Survey instruments The questionnaire included sections on demographic data, medical history and medication use, scabies history and treatment, pruritus severity and duration, behavioral changes after infestation, anxiety symptoms, and dermatology-related quality of life. Pruritus severity was assessed using a numeric rating scale from 0 (no itch) to 10 (worst imaginable itch). Pre-diagnosis and post-treatment pruritus durations were self-reported and converted to days. Behavioral changes were assessed using Likert-scale items (1-5) designed to evaluate avoidance behaviors, hygiene practices, checking behaviors, and perceived long-term behavioral impact. A composite behavioral change score was calculated by averaging the behavioral item scores, with higher scores indicating greater behavioral impact associated with scabies. The exploratory behavioral items were specifically developed for this study based on commonly observed behavioral responses in clinical practice as well as previous literature addressing scabies-related stigma, avoidance behaviors, and hygiene-related responses (Supplementary Table S1). These items were intended to assess excessive or persistent behaviors extending beyond routine medical recommendations. The exploratory behavioral change items demonstrated good internal consistency in the current study population (Cronbach’s alpha = 0.869). Quality of life was assessed using the Dermatology Life Quality Index (DLQI), a validated dermatology-specific instrument [13]. The DLQI consists of 10 items scored on a 4-point Likert scale (0–3), yielding a total score ranging from 0 to 30, with higher scores indicating greater quality-of-life impairment. The Turkish version of the DLQI has been validated and shown to be reliable in dermatological populations [14]. In the current study population, the DLQI demonstrated excellent reliability (Cronbach’s alpha = 0.951). Anxiety symptoms were measured using the Generalized Anxiety Disorder-7 (GAD-7) questionnaire, a validated screening tool for generalized anxiety [15]. The Turkish version of the GAD-7 has been validated and demonstrated good psychometric properties in clinical populations [16]. The GAD-7 also demonstrated good reliability in the current study population (Cronbach’s alpha = 0.816). Ethics Ethical approval for the study was obtained from the Marmara University Faculty of Medicine Non-Interventional Clinical Research Ethics Committee (Approval No. 09.2026.26-00045; January 20, 2026). This study was conducted in accordance with the principles of the Declaration of Helsinki. Statistical analysis Statistical analyses were performed using SPSS (version 25.0). Continuous variables are reported as medians with interquartile ranges due to non-normal distributions. Categorical variables are reported as counts and percentages. Group comparisons were conducted using Mann–Whitney U or Kruskal–Wallis tests as appropriate. Categorical variables were compared using chi-square or Fisher’s exact tests. Associations between continuous variables were evaluated using Spearman correlation coefficients. Variables significant in univariate analyses or deemed clinically relevant were included in a multivariable linear regression model with robust standard errors to identify independent associations with quality-of-life impairment. A p-value < 0.05 was considered statistically significant. All tests were two-sided. There were no missing data for the variables included in the analyses. Results Participant characteristics A total of 173 participants were included in the final analysis. The median age was 37 years (IQR 27–46), and 48.6% were female. Atopic predisposition was reported by 36.4% of participants, and nodular lesions were present in 43.4%. Recurrent scabies (≥ 2 lifetime episodes) was documented in 13.9%. Polypharmacy, psychiatric medication use, and immunosuppression were relatively uncommon. The study population represented diverse occupational groups, predominantly white-collar/professional occupations (63.0%), followed by students (12.1%), service/manual labor groups (8.7%), retirees (8.1%), and homemakers (5.8%). Detailed demographic and clinical characteristics are presented in Table 1. Table 1Demographic and clinical characteristics of participants (n = 173)VariableValueAge, years37 (27–46)Female, n (%)84 (48.6)Married, n (%)79 (45.7)Atopy (any), n (%)63 (36.4)Dust mite allergy, n (%)29 (16.8)Nodules present, n (%)75 (43.4)≥ 2 scabies episodes, n (%)24 (13.9)Polypharmacy (≥ 3 medications), n (%)5 (2.9)Psychiatric medication use, n (%)3 (1.7)Immunosuppression, n (%)8 (4.6)Occupational category, n (%) White-collar/professional occupations*109 (63.0) Students21 (12.1) Service/manual labor group15 (8.7) Retired14 (8.1) Homemakers10 (5.8) Other/unspecified4 (2.3)*White-collar/professional occupations included finance/banking/sales/management professions, technical/professional occupations, and healthcare/education professionals. All participants were recruited from Istanbul, a large cosmopolitan metropolitan city in Türkiye Demographic and clinical characteristics of participants (n = 173) *White-collar/professional occupations included finance/banking/sales/management professions, technical/professional occupations, and healthcare/education professionals. All participants were recruited from Istanbul, a large cosmopolitan metropolitan city in Türkiye The mean time from treatment completion to survey completion was 28.8 ± 18.0 months, with a median of 28.0 months (range: 1.1–61.3 months). Exploratory correlation analyses demonstrated no significant association between time elapsed since treatment and GAD-7 scores (Spearman’s rho = -0.042, p = 0.586), DLQI scores (rho = 0.036, p = 0.637), or composite behavioral change scores (rho = -0.082, p = 0.285). These relationships are illustrated in Fig. 1. Scatter plots demonstrating the relationships between time since treatment completion and (A) Dermatology Life Quality Index (DLQI) scores, (B) Generalized Anxiety Disorder-7 (GAD-7) scores, and (C) composite behavioral change scores. The composite behavioral change score was calculated by averaging the exploratory Likert-scale behavioral item scores, with higher scores indicating greater behavioral impact associated with scabies. No significant correlations were observed between elapsed time since treatment and DLQI scores (Spearman’s rho = 0.036, p = 0.637), GAD-7 scores (rho = -0.042, p = 0.586), or behavioral change scores (rho = -0.082, p = 0.285). Vertical and horizontal reference lines indicate the median values of the x- and y-axes, respectively Similar findings were observed in an exploratory subgroup analysis restricted to participants who completed the survey within 6 months after treatment (Supplementary Table S2). Symptom burden and patient-reported outcomes Pruritus severity during active infestation was high, with a median score of 8.0 (7.0–10.0). Median pre-diagnosis pruritus duration was 14.0 (7.0–30.0) days, while post-treatment pruritus persisted for a median of 7.0 (4.2–24.0) days. The median behavioral change composite score was 3.2 (2.5–4.0). Median GAD-7 and DLQI scores were 4.0 (2.0–7.0) and 8.0 (1.0–18.0), respectively, reflecting substantial variability in psychological burden and quality-of-life impairment. These distributions are summarized in Table 2. Table 2Patient-reported outcomesOutcomeMedian (IQR)Pruritus severity (0–10)8.0 (7.0–10.0)DLQI total (0–30)8.0 (1.0–18.0)GAD-7 total (0–21)4.0 (2.0–7.0)Behavioral change composite (1–5)3.2 (2.5–4.0)Pre-diagnosis pruritus (days)14.0 (7.0–30.0)Post-treatment pruritus (days)7.0 (4.2–24.0)Abbreviations DLQI Dermatology Life Quality Index, GAD-7 Generalized Anxiety Disorder-7 Patient-reported outcomes Abbreviations DLQI Dermatology Life Quality Index, GAD-7 Generalized Anxiety Disorder-7 Among individual behavioral items, repetitive skin checking demonstrated the highest median score, followed by avoidance and hygiene-related behaviors (Table 3). Table 3Behavioral Change ItemsItemMedian (IQR)Avoiding physical contact4.0 (2.0–5.0)Avoiding social gatherings3.0 (1.0–5.0)Excessive showering3.0 (2.0–5.0)Excessive laundry4.0 (2.0–5.0)Repetitive skin checking4.0 (3.0–5.0)Negative social impact3.0 (2.0–5.0) Behavioral Change Items Correlation analyses Spearman correlation analyses are presented in Table 4. Pruritus severity showed a modest but statistically significant positive correlation with behavioral change (ρ = 0.27, p < 0.001) and with post-treatment pruritus duration (ρ = 0.19, p = 0.02). However, pruritus severity was not significantly correlated with anxiety (ρ = 0.09, p = 0.25) or DLQI scores (ρ = 0.11, p = 0.13). Table 4Spearman’s correlation coefficients between clinical and psychosocial variablesVariable Pairρp-valuePruritus ↔ Behavioral change0.27< 0.001Pruritus ↔ DLQI0.110.13Pruritus ↔ GAD-70.090.25Behavior ↔ DLQI0.210.005Behavior ↔ GAD-70.30< 0.001GAD-7 ↔ DLQI0.38< 0.001Abbreviations DLQI Dermatology Life Quality Index, GAD-7 Generalized Anxiety Disorder-7 Spearman’s correlation coefficients between clinical and psychosocial variables Abbreviations DLQI Dermatology Life Quality Index, GAD-7 Generalized Anxiety Disorder-7 In contrast, DLQI scores demonstrated a moderate, statistically significant positive correlation with anxiety (ρ = 0.38, p < 0.001) and a weaker but significant correlation with behavioral change (ρ = 0.21, p = 0.005). Behavioral change was also significantly correlated with anxiety (ρ = 0.30, p < 0.001). Longer pre-diagnosis pruritus duration was significantly associated with prolonged post-treatment pruritus (ρ = 0.22, p = 0.01), but showed no significant correlations with pruritus severity, anxiety, behavioral change, or DLQI scores. Group comparisons Participants with nodular lesions experienced significantly greater quality-of-life impairment compared with those without nodules (median DLQI 11.0 vs. 5.0, p < 0.001). They also reported higher anxiety scores (median GAD-7 5.0 vs. 3.0, p < 0.001) and longer post-treatment pruritus duration (median 14.0 vs. 7.0 days, p = 0.03). Pre-infestation fear of scabies was associated with significantly higher anxiety scores (median 7.0 vs. 3.5, p < 0.001) and greater behavioral change (median 3.9 vs. 3.1, p < 0.001), although differences in DLQI scores did not reach statistical significance (p = 0.09). Female participants reported higher anxiety scores (median 5.0 vs. 3.0, p = 0.009) and greater behavioral change (median 3.6 vs. 3.0, p = 0.04), while DLQI scores did not differ significantly by sex (p = 0.73). Atopic predisposition and prior history of pruritic dermatoses were each associated with longer post-treatment pruritus duration (both p = 0.02), without significant differences in DLQI or anxiety scores. Immunosuppressed participants had higher anxiety scores compared with non-immunosuppressed individuals (median 8.0 vs. 4.0, p = 0.03), whereas quality-of-life impairment did not differ significantly. Participants with polypharmacy demonstrated lower DLQI scores (median 1.0 vs. 8.5, p = 0.01); however, this subgroup was small. Multivariable analysis In multivariable linear regression analysis with robust standard errors (Table 5), the presence of nodular lesions independently predicted greater quality-of-life impairment (B = 3.25, p = 0.047). Increasing age was associated with a small inverse association with DLQI scores (B = − 0.10, p = 0.045). Pruritus severity, behavioral change, pre-diagnosis pruritus duration, female sex, and scabies-related fear were not independently associated with quality-of-life impairment after adjustment. Table 5Multivariable linear regression analysis of factors associated with DLQI scoresPredictorBSE (robust)95% CIp-valuePruritus severity0.630.45[-0.25, 1.51]0.15Behavioral change0.880.81[-0.71, 2.47]0.27Pre-diagnosis duration0.010.02[-0.03, 0.05]0.41Age-0.100.05[-0.20, 0.01]0.045Female sex0.181.55[-2.86, 3.22]0.90Nodules3.251.63[0.06, 6.44]0.047Scabies fear1.702.08[-2.38, 5.78]0.41 Multivariable linear regression analysis of factors associated with DLQI scores Discussion Dermatologic diseases are well known to exert a substantial impact on patients’ quality of life. Bodily dissatisfaction, anxiety, and depression have been commonly reported among people affected with skin diseases [17, 18]. Psychological impacts result from altered physical appearance, social stigma, and debilitating disease symptoms whose severity is determined by the size of lesions, the affected body parts, and symptom duration [19, 20]. Despite their limited number, studies assessing quality of life in scabies patients have reported markedly heterogeneous outcomes, ranging from mild to very severe impairment [10, 21–26]. In our study, scabies had a considerable effect on the quality of life, with more than half of the patients experiencing moderate to extremely large impairment. Previous studies assessing the impact of scabies on DLQI reported that “symptoms and feelings” were the most affected domain, followed by daily activities, personal relationships, and leisure [21–26]. In our study, however, “personal relationships” emerged as the most impaired domain, followed by “symptoms and feelings” and “leisure”. These results could be explained by social concerns, fear of transmission, and avoidance behaviors, particularly in adult patients. Pruritus severity was high in the study population, but was not significantly associated with quality-of-life impairment or anxiety. Patients with comparable pruritus levels demonstrated wide variability in DLQI scores, suggesting that psychosocial factors substantially shape disease burden. This observation is consistent with previous work showing that the impact of pruritic skin diseases often exceeds what would be expected based on clinical severity alone [27]. In contrast, quality-of-life impairment showed moderate and significant associations with anxiety and behavioral change. Behavioral change scores were also significantly correlated with both pruritus severity and anxiety, suggesting that behavioral adaptations may represent an important intermediary through which symptoms translate into patient-reported burden. In our analysis, itch severity showed weaker associations with DLQI than anxiety and behavioral scores. Given that family physicians are frequently the first, and sometimes the only point of contact for patients with scabies, these results underscore the need for assessments that extend beyond visible lesions and symptom intensity, even when symptoms appear clinically mild. Furthermore, nodular scabies was associated with significantly worse outcomes, including higher DLQI scores, higher anxiety levels, and longer post-treatment pruritus duration, and remained an independent predictor of quality-of-life impairment in multivariable analysis. Nodular lesions are thought to reflect persistent hypersensitivity reactions and ongoing immune activation, which may explain their association with prolonged symptoms and distress [28]. In primary care practice, the presence of nodules may therefore serve as a clinical marker of chronicity and increased psychosocial risk, warranting closer follow-up or early referral. Longer pre-diagnosis pruritus duration was associated with prolonged post-treatment pruritus, suggesting that delayed recognition of scabies may be linked to persistent symptoms after treatment. Because of the cross-sectional design, causality cannot be established. However, prolonged exposure to mite antigens could contribute to ongoing immune activation and continued symptoms. Previous studies have reported diagnostic difficulties in routine practice, especially in early or atypical cases, which may delay appropriate management [28, 29]. These findings support the need for earlier diagnosis in primary care to reduce both transmission and prolonged post-treatment symptoms. Higher behavioral change scores were positively associated with quality-of-life impairment (ρ = 0.211, p = 0.005). To our knowledge, this is the first study to systematically examine behavioral changes associated with scabies and their relationship with quality of life and psychological distress. A community-based qualitative study conducted in Guinea-Bissau highlighted the role of stigma, fear of transmission, and socioeconomic constraints in shaping health-seeking behaviours and social interactions related to scabies [30]. However, that study focused on community perceptions and practices rather than patient-level behavioral adaptations. In contrast, the present study extends the existing literature by systematically examining behavioral changes following scabies infestation and quantitatively linking these behaviors to quality-of-life impairment and psychological distress. Our findings suggest that comparable behavioral mechanisms may also play a meaningful role in shaping the overall burden of scabies, particularly in the primary care setting, where such behaviors are often first recognized. In the primary care setting, such behaviors are often readily identifiable through routine history-taking. Early counseling and reassurance may help prevent the consolidation of these behaviors, highlighting primary care as an ideal setting for early behavioral intervention. Pruritus severity was positively correlated with behavioral change, indicating that increased itching was associated with more avoidance and hygiene-related behaviors. Importantly, the behavioral changes assessed in this study were not limited to routine hygiene measures recommended during treatment, but also included excessive or persistent behaviors that may contribute to ongoing psychosocial burden. Increased washing and hygiene practices may aggravate skin irritation, which could contribute to ongoing symptoms [8, 9]. Addressing these behaviors early in primary care, through simple counseling and reassurance, may help prevent their persistence. Interestingly, despite the expectation that these behaviors and psychological effects might attenuate over time, no significant correlations were identified between time elapsed since treatment and psychological or behavioral outcome measures, suggesting that some effects associated with scabies may persist beyond the active infestation period. Anxiety showed the strongest association with quality-of-life impairment. Anxiety scores were also significantly higher in female and immunosuppressed patients. Previous adult studies have reported similar associations between anxiety severity and quality-of-life impairment scores using validated instruments [10, 21]. These findings indicate that anxiety contributes to quality-of-life impairment in adults with scabies. Recent pediatric data indicate a different pattern. Sarı et al. reported that children with scabies had significant sleep disturbance and reduced dermatology-related quality of life, whereas anxiety and depression scores were similar to those of healthy controls. In that study, sleep problems appeared to account for most of the impairment [11]. This difference may be related to age, shorter disease duration, or different coping patterns in children. In adults, anxiety seems to be a more prominent issue, whereas in children, sleep disturbance appears to be more noticeable. In our multivariable linear regression analysis, age was negatively associated with quality of life. This means that younger participants, particularly adolescents and young adults, tended to have higher DLQI scores and therefore reported poorer quality of life. These findings may indicate that the psychosocial burden of the disease is experienced differently depending on age. In children, the main difficulty may be related to physical discomfort, especially problems with sleep. In contrast, young adults may be more affected by concerns about appearance, possible stigma, and social interactions. For this reason, clinicians should pay attention not only to children but also to young adults when considering the psychosocial impact of scabies. Patients who reported pre-infestation fear of scabies had higher anxiety scores and greater behavioral change. This finding indicates that prior concern about scabies may be associated with increased psychological distress and behavioral responses after infestation. To our knowledge, the specific impact of pre-infestation scabies-related fear on anxiety and post-infestation behavioral responses has not been systematically examined in previous scabies-focused studies. Therefore, this finding may represent a novel observation, aligning conceptually, though not directly, with broader literature on health anxiety and symptom amplification in dermatological conditions. As such fears are often shaped during early healthcare encounters, clear communication, reassurance, and normalization of post-treatment symptoms should be considered core components of scabies management in primary care. Strengths One strength of this study is the use of multivariable linear regression to examine factors related to DLQI. This approach allowed us to consider several variables at the same time rather than relying only on simple correlations. Another strength is the use of widely accepted and validated scales, including DLQI and GAD-7. Using these instruments makes it easier to compare our findings with other studies in the dermatology literature. Finally, the study evaluated different aspects of the disease together, including physical symptoms (such as pruritus and nodules), anxiety levels, and behavioral changes. Considering these factors together provides a broader view of the burden of scabies. Limitations This study has several limitations. The cross-sectional design does not allow conclusions about causality between itch severity, behavioral responses, psychological distress, and quality-of-life impairment. The data were self-reported and may therefore have been affected by recall bias or social desirability bias. In addition, the relatively long interval between treatment completion and survey administration may have further increased the risk of recall bias. Symptom duration before diagnosis and after treatment was reported retrospectively and may not be fully accurate, although such information is commonly used in primary care practice. In addition, the exploratory behavioral change items were developed specifically for this study and were not based on a formally validated psychometric instrument, although they demonstrated good internal consistency and were informed by routine clinical observations and were associated with patient-reported outcomes. More detailed sociodemographic variables, including formal education level and rural-versus-urban residence, were not systematically assessed. Finally, the absence of a control group and the presence of concomitant atopic predisposition in some participants may have influenced symptom perception and limited the ability to fully distinguish scabies-related effects from other pruritic conditions. Conclusion In this study, quality-of-life impairment was more closely associated with anxiety, behavioral responses, and nodular presentation than with itch intensity alone. Brief anxiety assessment and focused counseling during routine care may help improve patient-reported outcomes. Supplementary Information Supplementary Material 1. Supplementary Material 2. Supplementary Material 3. Acknowledgements None. Abbreviations Dermatology life quality ındex Generalized anxiety disorder-7 International alliance for the control of scabies Interquartile range Authors’ contributions OA: Conceptualization, Methodology, Investigation, Data curation, Writing – original draft.OT: Methodology, Data curation, Formal analysis, Writing – review & editing, Supervision.All authors read and approved the final manuscript. Funding The authors received no financial support for the research, authorship, or publication of this article. Data availability The datasets generated and/or analyzed during the current study are available from the corresponding author on reasonable request. Declarations Ethics approval and consent to participate Ethical approval for the study was obtained from the Marmara University Faculty of Medicine Non-Interventional Clinical Research Ethics Committee (Approval No. 09.2026.26-00045; January 20, 2026). Written informed consent was obtained from all participants before participation in the study. This study was conducted in accordance with the principles of the Declaration of Helsinki. Consent for publication Not applicable. Competing interests The authors declare no competing interests. Footnotes Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations. References Associated Data Supplementary Materials Supplementary Material 1. Supplementary Material 2. Supplementary Material 3. Data Availability Statement The datasets generated and/or analyzed during the current study are available from the corresponding author on reasonable request.